Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Chem Phys Lipids ; 235: 105050, 2021 03.
Article in English | MEDLINE | ID: mdl-33422547

ABSTRACT

Phospholipase C (PLC) ß and ε enzymes hydrolyze phosphatidylinositol (PI) lipids in response to direct interactions with heterotrimeric G protein subunits and small GTPases, which are activated downstream of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). PI hydrolysis generates second messengers that increase the intracellular Ca2+ concentration and activate protein kinase C (PKC), thereby regulating numerous physiological processes. PLCß and PLCε share a highly conserved core required for lipase activity, but use different strategies and structural elements to autoinhibit basal activity, bind membranes, and engage G protein activators. In this review, we discuss recent structural insights into these enzymes and the implications for how they engage membranes alone or in complex with their G protein regulators.


Subject(s)
Cell Membrane/metabolism , Phosphoinositide Phospholipase C/metabolism , Phospholipase C beta/metabolism , Cell Membrane/chemistry , Humans , Models, Molecular , Phosphoinositide Phospholipase C/chemistry , Phospholipase C beta/chemistry , Protein Conformation
2.
Commun Biol ; 3(1): 445, 2020 08 14.
Article in English | MEDLINE | ID: mdl-32796910

ABSTRACT

Phospholipase Cε (PLCε) generates lipid-derived second messengers at the plasma and perinuclear membranes in the cardiovascular system. It is activated in response to a wide variety of signals, such as those conveyed by Rap1A and Ras, through a mechanism that involves its C-terminal Ras association (RA) domains (RA1 and RA2). However, the complexity and size of PLCε has hindered its structural and functional analysis. Herein, we report the 2.7 Å crystal structure of the minimal fragment of PLCε that retains basal activity. This structure includes the RA1 domain, which forms extensive interactions with other core domains. A conserved amphipathic helix in the autoregulatory X-Y linker of PLCε is also revealed, which we show modulates activity in vitro and in cells. The studies provide the structural framework for the core of this critical cardiovascular enzyme that will allow for a better understanding of its regulation and roles in disease.


Subject(s)
Phosphoinositide Phospholipase C/chemistry , Phosphoinositide Phospholipase C/metabolism , Regulatory Sequences, Nucleic Acid/genetics , Animals , Crystallography, X-Ray , Enzyme Stability , Models, Biological , Mutation/genetics , Protein Domains , Protein Structure, Secondary , Rats , Transition Temperature
3.
Urology ; 139: 156-160, 2020 05.
Article in English | MEDLINE | ID: mdl-32081673

ABSTRACT

OBJECTIVE: To evaluate the value of the voiding cystourethrogram (VCUG) in children with multicystic dysplastic kidney (MCDK) who have a normal versus abnormal contralateral kidney and bladder ultrasound (US), and assess the risk of having vesicoureteral reflux (VUR) or urinary tract infection (UTI) based on the US results. METHODS: A retrospective chart review including children with unilateral MCDK with postnatal US and VCUG available at our institution between January 2008 and September 2017 was performed. Analysis was done to find association between abnormal contralateral US and contralateral VUR and UTI. RESULTS: One hundred and fifty-six children were analyzed; 118(75.6%) patients had a normal contralateral kidney US, while 38(24.4%) had abnormal US. The rate of severe contralateral VUR (grade IV and V) was 2 (1.7%) and 5 (13.2%) in children with normal and abnormal contralateral US, respectively. The risk analysis demonstrated a significant association between severe VUR on the contralateral kidney and an abnormal contralateral US (odds ratio = 7.73; 95%CI: 1.43-41.81; P = 0.018) and no significant association with UTI (odds ratio = 1.58; 95%CI: 0.50-4.94; P = 0.435). CONCLUSION: Our data suggests, the rate of severe contralateral VUR in children with unilateral MCDK and normal contralateral kidney is low. VCUG should be considered for infants with proven MCKD and alterations on the contralateral kidney on US. Following patients with MCDK and normal contralateral kidney without the use of VCUG is a reasonable approach, unless there is development of signs and symptoms of recurrent UTI or deterioration of the renal function. We found that abnormal contralateral kidney US was associated with severe VUR.


Subject(s)
Kidney/diagnostic imaging , Multicystic Dysplastic Kidney , Ultrasonography/methods , Urinary Tract Infections , Vesico-Ureteral Reflux , Child , Female , Follow-Up Studies , Humans , Infant , Male , Multicystic Dysplastic Kidney/complications , Multicystic Dysplastic Kidney/diagnosis , Multicystic Dysplastic Kidney/physiopathology , Risk Assessment/methods , Risk Factors , Ureter/diagnostic imaging , Urinary Bladder/diagnostic imaging , Urinary Tract Infections/diagnosis , Urinary Tract Infections/etiology , Urinary Tract Infections/prevention & control , Urodynamics , Urography/methods , Vesico-Ureteral Reflux/diagnosis , Vesico-Ureteral Reflux/etiology
4.
J Biol Chem ; 293(45): 17477-17490, 2018 11 09.
Article in English | MEDLINE | ID: mdl-30242131

ABSTRACT

Phospholipase C (PLC) enzymes produce second messengers that increase the intracellular Ca2+ concentration and activate protein kinase C (PKC). These enzymes also share a highly conserved arrangement of core domains. However, the contributions of the individual domains to regulation are poorly understood, particularly in isoforms lacking high-resolution information, such as PLCϵ. Here, we used small-angle X-ray scattering (SAXS), EM, and functional assays to gain insights into the molecular architecture of PLCϵ, revealing that its PH domain is conformationally dynamic and essential for activity. We further demonstrate that the PH domain of PLCß exhibits similar dynamics in solution that are substantially different from its conformation observed in multiple previously reported crystal structures. We propose that this conformational heterogeneity contributes to subfamily-specific differences in activity and regulation by extracellular signals.


Subject(s)
Molecular Dynamics Simulation , Pleckstrin Homology Domains , Type C Phospholipases/chemistry , Animals , Humans , Mutation , Rats , Type C Phospholipases/genetics , Type C Phospholipases/metabolism
5.
Laryngoscope ; 128(2): 386-392, 2018 02.
Article in English | MEDLINE | ID: mdl-28688192

ABSTRACT

OBJECTIVES/HYPOTHESIS: To assess the baseline awareness of human papillomavirus (HPV) infection as a cause of head and neck cancer (HNC) to design improved targeted screening and education efforts. STUDY DESIGN: Retrospective review of collected survey at a cancer screening event. METHODS: This was a screening event at three hospitals and one community center in Miami, Florida. Participants were recruited throughout the Greater Miami area. Descriptive statistics were used to summarize the demographic characteristics of those who were aware of HPV and those who were not. Adjusted odds ratios, odds ratios, and χ2 tests were used in statistical analysis. RESULTS: A total of 196 women and 112 men were screened across four sites, with 187 participants at hospital-based events and 124 participants at the community-based event. Forty percent of respondents had heard of HPV, and 28.0% identified HPV as a risk factor for HNC. Non-Hispanic and Hispanic respondents were 3.309 and 2.445 times, respectively, more likely than Haitian respondents to have heard of HPV. Women were 2.488 times more likely than men to be aware of HPV. College graduates were 2.268 times more likely than those with less than a college degree to be aware of HPV. Younger respondents were more likely to be aware of HPV. Of those who identified HPV as a risk factor for HNC, 95.4% also correctly identified smoking and 75.9% also correctly identified alcohol as risk factors. CONCLUSIONS: Disparities in HPV and HNC awareness were noted between gender, age, education level, and ethnicity. LEVEL OF EVIDENCE: NA. Laryngoscope, 128:386-392, 2018.


Subject(s)
Early Detection of Cancer , Head and Neck Neoplasms/virology , Health Knowledge, Attitudes, Practice , Papillomaviridae , Papillomavirus Infections/virology , Adult , Age Factors , Aged , Early Detection of Cancer/psychology , Educational Status , Ethnicity/psychology , Female , Florida , Head and Neck Neoplasms/prevention & control , Head and Neck Neoplasms/psychology , Humans , Male , Middle Aged , Papillomavirus Infections/complications , Papillomavirus Infections/psychology , Retrospective Studies , Risk Factors , Sex Factors , Surveys and Questionnaires
6.
Diabetes ; 65(10): 2943-53, 2016 10.
Article in English | MEDLINE | ID: mdl-27385157

ABSTRACT

Lorcaserin is a serotonin 5-hydroxytryptamine 2c receptor agonist effective in treating obesity. Studies in rodents have shown that lorcaserin acts in the brain to exert its weight-reducing effects, but this has not yet been studied in humans. We performed a randomized, placebo-controlled, double-blind trial with 48 obese participants and used functional MRI to study the effects of lorcaserin on the brain. Subjects taking lorcaserin had decreased brain activations in the attention-related parietal and visual cortices in response to highly palatable food cues at 1 week in the fasting state and in the parietal cortex in response to any food cues at 4 weeks in the fed state. Decreases in emotion- and salience-related limbic activity, including the insula and amygdala, were attenuated at 4 weeks. Decreases in caloric intake, weight, and BMI correlated with activations in the amygdala, parietal, and visual cortices at baseline. These data suggest that lorcaserin exerts its weight-reducing effects by decreasing attention-related brain activations to food cues (parietal and visual cortices) and emotional and limbic activity (insula, amygdala). Results indicating that baseline activation of the amygdala relates to increased efficacy suggest that lorcaserin would be of particular benefit to emotional eaters.


Subject(s)
Anti-Obesity Agents/therapeutic use , Benzazepines/therapeutic use , Brain/drug effects , Brain/physiology , Body Weight/drug effects , Cues , Double-Blind Method , Emotions/physiology , Energy Intake , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Obesity/drug therapy , Obesity/physiopathology , Weight Loss/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...